Skip to content
We often talk about the exciting jumps in technology and innovation that improve and save lives. What is less frequently discussed is how regulation […]
BIO 2025: The innovation race vs. the regulatory pace Read More »
Over 7 million Americans live with Alzheimer’s disease, according to the Alzheimer’s Association. For June’s Alzheimer’s Awareness Month, Bio.News sat down with the Alzheimer’s
Alzheimer’s Awareness Month: What to know about a disease impacting millions Read More »
Established in 2012, the Pediatric Priority Review (PPRV) program offers a powerful incentive for companies to develop treatments for rare conditions affecting children. Even
BIO 2025: What is the PRV program and why does it matter? Read More »
The 2025 Biotechnology Innovation Organization (BIO) International Convention highlighted why we – the biotech industry – do what we do. In one word: patients.
BIO 2025: ‘Behind every data point there is a person’ Read More »
The rare disease patient community is the beating heart of the Biotechnology Innovation Organization’s (BIO) mission. Whether it is driving policy that supports innovation,
BIO 2025: Rare disease patients can’t wait Read More »
Food and Drug Administration (FDA) Commissioner Martin A. Makary, M.D., M.P.H., sat down with the Biotechnology Innovation Organization (BIO) President and CEO John F.
BIO 2025: Commissioner Martin Makary, M.D., M.P.H., discusses vision for FDA Read More »
Public health advocates are reevaluating the vaccine landscape, revisiting long-held assumptions about vaccine policy during both public health emergencies and periods of relative calm.
BIO 2025: How do we talk about vaccines now? Read More »
From drug discovery to clinical trials, AI is being used, studied, refined, and advanced as a means to slingshot biotech innovations into the future
BIO 2025: AI Summit highlights role of collaboration in reaching the next frontier Read More »
America, for decades, has been the undisputed global leader when it comes to innovative drug development. But this leadership is now at risk. “We
BIO Coffee Chat: ORPHAN Cures Act key to fighting rare disease Read More »
In April 2025, the Department of Health and Human Services (HHS) announced it would disband the Advisory Committee on Heritable Disorders in Newborns and
Patient’s mother advocates for newborn screening program reform Read More »
